CELGEN PEARL MOISTURE Solution by BBHC CO., LTD / STC Nara Co., Ltd 76731-205

CELGEN PEARL MOISTURE Solution by

Drug Labeling and Warnings

CELGEN PEARL MOISTURE Solution by is a Otc medication manufactured, distributed, or labeled by BBHC CO., LTD, STC Nara Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

CELGEN PEARL MOISTURE SOLUTION- niacinamide, adenosine liquid 
BBHC CO., LTD

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

76731-205

Active ingredient

Niacinamide (2.00%)

Adenosine (0.04%)

Purpose

Skin Brightening

Anti wrinkle

Uses

Helps improve skin brightness and wrinkle care.

Helps moisturize dehydrated skin.

Warnings

For external use only.

Do not use on damaged or broken skin.

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

rash occurs.

Keep out of reach of children

If porducts is swallowed, get medical help or contact a Poison Control Center right away.

Directions

Spray to cover the full facial area and gently tap with fingertips. Use this product in the morning and at night after washing.

Inactive ingredients

Water, Glycerin, PEG-60 Hydrogenated Castor Oil, 1,2-Hexanediol, Caprylyl Glycol, Oryzanol, Caprylhydroxamic Acid, Propanediol, Stearic Acid, Cetyl Ethylhexanoate, Beeswax, Disodium EDTA, Citric Acid, Cetearyl Alcohol, Sodium Citrate, Sodium Hyaluronate, Ethylhexylglycerin, Geranium Maculatum Extract, Sodium Chloride, Glucose

Package Label

125ml NDC: <a href=/NDC/76731-205-01>76731-205-01</a> Label

CELGEN PEARL MOISTURE SOLUTION 
niacinamide, adenosine liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 76731-205
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE2 g  in 100 mL
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE0.04 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
GAMMA ORYZANOL (UNII: SST9XCL51M)  
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
PROPANEDIOL (UNII: 5965N8W85T)  
CETYL ETHYLHEXANOATE (UNII: 134647WMX4)  
YELLOW WAX (UNII: 2ZA36H0S2V)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
GERANIUM MACULATUM ROOT (UNII: 93IXI5B6OJ)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
ANHYDROUS DEXTROSE (UNII: 5SL0G7R0OK)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
CAPRYLHYDROXAMIC ACID (UNII: UPY805K99W)  
POLYOXYL 60 HYDROGENATED CASTOR OIL (UNII: 02NG325BQG)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 76731-205-01125 mL in 1 BOTTLE; Type 0: Not a Combination Product09/03/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other09/03/202005/01/2023
Labeler - BBHC CO., LTD (689522401)
Registrant - STC Nara Co., Ltd (689135085)
Establishment
NameAddressID/FEIBusiness Operations
STC Nara Co., Ltd689135085manufacture(76731-205)

Revised: 5/2023
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.